comprehensive -WSS

comprehensive

author：explore 2025-10-02 01:08:35 - browse：93496

Senate Finance Committee Chair Ron Wyden (D-Ore.) Leah Millis/Pool via AP

WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to clamp down on drug middlemen, but kicked the can down the road on some of the more challenging policies.

The bill would offer some more transparency into the business practices of pharmacy benefit managers, ensure PBMs aren’t skimming off of the money they send to insurers, prohibit them from overcharging insurers, and ensure certain fees in the Medicare program aren’t tied to a drug’s price.

“It’s pretty hard to get 26 votes around here,” Finance Chair Ron Wyden (D-Ore.) said after the vote. “So we’re thrilled.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Videos point to link between seizures and unexplained toddler deaths

explore

WSS

Feng Zhang, Grail founder join forces on new gene editing startup

U.S. death rates show how politics are affecting public health

Antibiotic resistance and the global rise in human conflict

Clinicians often fail to acknowledge the pain caused by long Covid

Congress: Prevent baby formula shortages by passing a new bill

J&J reports mixed data on next

hotspot

comprehensive

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Ozempic cut risk of death in diabetes patients with chronic kidney disease

State Dept. review finds Biden bears some blame for Afghanistan failures

Beyond aggravation: Constipation is an American epidemic

FDA approval of Sarepta Duchenne genetic therapy gives me hope

AdventHealth escalates lawsuit against insurance vendor Multiplan

Jerome Adams on the need for new antivirals for Covid

Pharma’s losing bet in New Jersey

Novavax promises a turnaround & Lilly roils the obesity market

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

focus

Pharma’s losing bet in New Jersey

Morgan Health, with ambitious aims, wants you to know it’s still here

U.S. death rates show how politics are affecting public health

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Hospitals need to get ahead of regulations on climate change

Guardant Health colon cancer test endorsed by FDA advisory panel

focus

explore

explore

hotspot